Screener
Aclaris Therapeutics ACRS Single Reportable — Research And Development Project Spend
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept acrs:ResearchAndDevelopmentProjectSpend.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
| (In thousands) | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Modzatinib | 370 | 1,118 | 861 | 2,926 |
| ATI-9494 | 3,056 | 871 | 5,281 | 1,549 |
| Discovery | 1,972 | 749 | 3,411 | 1,417 |
| Total research and development project expense(1) | 13,632 | 7,003 | 24,109 | 14,160 |
| Personnel | 3,036 | 2,984 | 6,317 | 5,911 |
| Other research and development(2) | 1,398 | 1,462 | 3,297 | 2,962 |
| Total research and development | 18,066 | 11,449 | 33,723 | 23,033 |
| General and administrative(3) | 6,048 | 5,386 | 12,791 | 11,525 |
Item 1. Financial Statements
FAQ
- What is Aclaris Therapeutics's single reportable — research and development project spend?
- Aclaris Therapeutics (ACRS) reported single reportable — research and development project spend of $13.63M in Q2 2026.
- How has Aclaris Therapeutics's single reportable — research and development project spend changed year-over-year?
- Aclaris Therapeutics's single reportable — research and development project spend increased by 94.7% year-over-year, from $7M to $13.63M.
- What does single reportable — research and development project spend mean?
- Reflects the direct capital or operational expenditure allocated specifically to ongoing research and development projects within the segment. It highlights the company's commitment to innovation and the advancement of its product pipeline. This metric is a key indicator of future growth potential and strategic investment in new therapeutic candidates.
Ask your AI about Aclaris Therapeutics's single reportable — research and development project spend.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude